The Physicians Committee for Responsible Medicine (PCRM) presents "The FDA ISTAND Program: A Guide to Replacing Animal Experiments with Your Method." During webinar, Dr. Michael Phelan will describe his experiences as the lead of the first ever submission accepted into the ISTAND program. He will provide a step-by-step guide to preparing for and completing each phase of the ISTAND program. Attendees will learn how to best position their own technologies for ISTAND submission and what the impacts of qualification might be.
PRESS RELEASE
7 January 2026
The FDA ISTAND Program: A Guide To Replacing Animal Experiments With Your Method, January 28, 2026, 1:00 p.m. (EST), via Webinar
Bergeson & Campbell
Contributor
Bergeson & Campbell, P.C. is a Washington D.C. law firm focusing on chemical product approval and regulation, product defense, and associated business issues. The Acta Group, B&C's scientific and regulatory consulting affiliate provides strategic, comprehensive support for global chemical registration, regulation, and sustained compliance. Together, we help companies that make and use chemicals commercialize their products, maintain compliance, and gain competitive advantage as they market their products globally.
The Physicians Committee for Responsible Medicine (PCRM) presents “The FDA ISTAND Program: A Guide to Replacing Animal Experiments with Your Method.” During webinar, Dr. Michael Phelan...